Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Microbiol ; 200(2): 281-289, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29075867

RESUMO

The mycolic acid layer and S-layer of Corynebacterium glutamicum have been considered as permeability barriers against lytic agents. EGTA, a calcium chelator, inhibited C. glutamicum growth at relatively lower concentrations compared with other Gram-positive bacteria. We investigated the effect of EGTA on C. glutamicum cell surface structures. Simultaneous addition of EGTA and lysozyme resulted in cell lysis, whereas addition of these reagents separately had no such effect. Analysis of cell surface proteins showed that CspB, an S-layer protein, was released into the culture media and degraded to several sizes upon EGTA treatment. These findings suggest that EGTA treatment causes release and proteolysis of the CspB protein, resulting in increased cell surface permeability. FE-SEM visualization further confirmed alteration of cell surface structures in EGTA-treated cells. This is the first report suggesting the importance of calcium ions in cell surface integrity of C. glutamicum.


Assuntos
Proteínas de Bactérias/metabolismo , Quelantes de Cálcio/farmacologia , Permeabilidade da Membrana Celular/efeitos dos fármacos , Estruturas da Membrana Celular/efeitos dos fármacos , Corynebacterium glutamicum/metabolismo , Ácido Egtázico/farmacologia , Muramidase/farmacologia , Membrana Celular/metabolismo , Corynebacterium glutamicum/crescimento & desenvolvimento , Glicoproteínas de Membrana/metabolismo , Proteínas de Membrana/metabolismo , Ácidos Micólicos/metabolismo
2.
Microb Cell Fact ; 13(1): 56, 2014 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-24731213

RESUMO

BACKGROUND: Among other advantages, recombinant antibody-binding fragments (Fabs) hold great clinical and commercial potential, owing to their efficient tissue penetration compared to that of full-length IgGs. Although production of recombinant Fab using microbial expression systems has been reported, yields of active Fab have not been satisfactory. We recently developed the Corynebacterium glutamicum protein expression system (CORYNEX®) and demonstrated improved yield and purity for some applications, although the system has not been applied to Fab production. RESULTS: The Fab fragment of human anti-HER2 was successfully secreted by the CORYNEX® system using the conventional C. glutamicum strain YDK010, but the productivity was very low. To improve the secretion efficiency, we investigated the effects of deleting cell wall-related genes. Fab secretion was increased 5.2 times by deletion of pbp1a, encoding one of the penicillin-binding proteins (PBP1a), mediating cell wall peptidoglycan (PG) synthesis. However, this Δpbp1a mutation did not improve Fab secretion in the wild-type ATCC13869 strain. Because YDK010 carries a mutation in the cspB gene encoding a surface (S)-layer protein, we evaluated the effect of ΔcspB mutation on Fab secretion from ATCC13869. The Δpbp1a mutation showed a positive effect on Fab secretion only in combination with the ΔcspB mutation. The ΔcspBΔpbp1a double mutant showed much greater sensitivity to lysozyme than either single mutant or the wild-type strain, suggesting that these mutations reduced cell wall resistance to protein secretion. CONCLUSION: There are at least two crucial permeability barriers to Fab secretion in the cell surface structure of C. glutamicum, the PG layer, and the S-layer. The ΔcspBΔpbp1a double mutant allows efficient Fab production using the CORYNEX® system.


Assuntos
Proteínas de Bactérias/genética , Proteínas de Escherichia coli/genética , Proteínas de Ligação às Penicilinas/genética , Peptidoglicano Glicosiltransferase/genética , Proteínas de Bactérias/metabolismo , Parede Celular/metabolismo , Corynebacterium glutamicum/metabolismo , Proteínas de Escherichia coli/metabolismo , Humanos , Fragmentos Fab das Imunoglobulinas/metabolismo , Mutação , Proteínas de Ligação às Penicilinas/deficiência , Proteínas de Ligação às Penicilinas/metabolismo , Peptidoglicano Glicosiltransferase/deficiência , Peptidoglicano Glicosiltransferase/metabolismo , Receptor ErbB-2/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...